94 related articles for article (PubMed ID: 19575889)
1. [Recent advances and applications of CXCR7].
Shen Q; Wang F
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):358-60. PubMed ID: 19575889
[No Abstract] [Full Text] [Related]
2. CXCR7 in tumorigenesis and progression.
Hou KL; Hao MG; Bo JJ; Wang JH
Chin J Cancer; 2010 Apr; 29(4):456-9. PubMed ID: 20346226
[TBL] [Abstract][Full Text] [Related]
3. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
5. SDF-1/CXCR7 axis regulates the proliferation, invasion, adhesion, and angiogenesis of gastric cancer cells.
Ma DM; Luo DX; Zhang J
World J Surg Oncol; 2016 Oct; 14(1):256. PubMed ID: 27716367
[TBL] [Abstract][Full Text] [Related]
6. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
Yamada K; Maishi N; Akiyama K; Towfik Alam M; Ohga N; Kawamoto T; Shindoh M; Takahashi N; Kamiyama T; Hida Y; Taketomi A; Hida K
Int J Cancer; 2015 Dec; 137(12):2825-36. PubMed ID: 26100110
[TBL] [Abstract][Full Text] [Related]
7. Endothelial CXCR7 regulates breast cancer metastasis.
Stacer AC; Fenner J; Cavnar SP; Xiao A; Zhao S; Chang SL; Salomonnson A; Luker KE; Luker GD
Oncogene; 2016 Mar; 35(13):1716-24. PubMed ID: 26119946
[TBL] [Abstract][Full Text] [Related]
8. CXCR7 regulates breast tumor metastasis and angiogenesis in vivo and in vitro.
Qian T; Liu Y; Dong Y; Zhang L; Dong Y; Sun Y; Sun D
Mol Med Rep; 2018 Mar; 17(3):3633-3639. PubMed ID: 29257351
[TBL] [Abstract][Full Text] [Related]
9. LYG-202 inhibits activation of endothelial cells and angiogenesis through CXCL12/CXCR7 pathway in breast cancer.
Zhao K; Yao Y; Luo X; Lin B; Huang Y; Zhou Y; Li Z; Guo Q; Lu N
Carcinogenesis; 2018 Apr; 39(4):588-600. PubMed ID: 29390073
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
11. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
12. CXCR7 impact on CXCL12 biology and disease.
Sánchez-Martín L; Sánchez-Mateos P; Cabañas C
Trends Mol Med; 2013 Jan; 19(1):12-22. PubMed ID: 23153575
[TBL] [Abstract][Full Text] [Related]
13. CXCR7: a novel tumor endothelial marker in renal cell carcinoma.
Maishi N; Ohga N; Hida Y; Akiyama K; Kitayama K; Osawa T; Onodera Y; Shinohara N; Nonomura K; Shindoh M; Hida K
Pathol Int; 2012 May; 62(5):309-17. PubMed ID: 22524658
[TBL] [Abstract][Full Text] [Related]
14. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
[TBL] [Abstract][Full Text] [Related]
15. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
16. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.
Miao Z; Luker KE; Summers BC; Berahovich R; Bhojani MS; Rehemtulla A; Kleer CG; Essner JJ; Nasevicius A; Luker GD; Howard MC; Schall TJ
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15735-40. PubMed ID: 17898181
[TBL] [Abstract][Full Text] [Related]
17. Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo.
Meijer J; Ogink J; Roos E
Br J Cancer; 2008 Nov; 99(9):1493-501. PubMed ID: 18854833
[TBL] [Abstract][Full Text] [Related]
18. CXCL12-CXCR7 signaling activates ERK and Akt pathways in human choriocarcinoma cells.
Tripathi V; Kumar R; Dinda AK; Kaur J; Luthra K
Cell Commun Adhes; 2014 Aug; 21(4):221-8. PubMed ID: 24450273
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis.
Yu PF; Huang Y; Xu CL; Lin LY; Han YY; Sun WH; Hu GH; Rabson AB; Wang Y; Shi YF
Oncogene; 2017 Feb; 36(6):840-849. PubMed ID: 27669436
[TBL] [Abstract][Full Text] [Related]
20. The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review).
Liao YX; Zhou CH; Zeng H; Zuo DQ; Wang ZY; Yin F; Hua YQ; Cai ZD
Int J Mol Med; 2013 Dec; 32(6):1239-46. PubMed ID: 24127013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
